Le Lézard
Classified in: Health, Business
Subjects: CHI, FOR

Children's Hospital of Philadelphia Urologist and Colleagues Address Unmet Global Burden of Surgical Disease in India


PHILADELPHIA, March 7, 2018 /PRNewswire-USNewswire/ -- Aseem R. Shukla, MD, a pediatric urologist at Children's Hospital of Philadelphia (CHOP), along with several of his colleagues from around the world, have created an innovative program to help address urological needs in India. The team is specifically addressing bladder exstrophy (BE), a complex, rare disorder that occurs during fetal development when the bladder does not form completely and drains onto the surface of the abdomen. If untreated, the disease raises the risk of serious infections and cancer, along with psychosocial complications.  

Aseem R. Shukla, MD, is an Attending Urologist and Director of Minimally Invasive Surgery in the Division of Urology at Children's Hospital of Philadelphia (CHOP)

With a population of 1.2 billion, India accounts for 21 percent of the global burden of disease. Approximately 500 babies are born there with BE each year, and the highly-specialized surgical knowledge required to treat BE is limited to a few major medical centers. The consequent lack of access is what prompted Dr. Shukla, along with Douglas Canning, MD, chief of the Division of Urology at CHOP, and several of their colleagues from around the world, to create a multi-institutional collaborative that leverages capabilities to alleviate the global burden of this surgically treatable disease, as reported today in JAMA Surgery.  

The article describes their project at Civil Hospital, a public hospital in Ahmedabad, India, between January 2009 and 2015. In addition to surgeons at Civil Hospital and CHOP, it joined together experts in urology from various other institutions, including Seattle Children's Hospital, Cincinnati Children's Hospital, and Sidra Medical and Research Center, in U.A.E.

"The international collaboration that we forged has transformed the care of children born with bladder exstrophy here in India and together, we are delivering care and surgical outcomes on par with the best hospitals in the world," said Dr. Rakesh Joshi, director of pediatric surgery at the Civil Hospital, and a lead author of the study. "We have seen our own surgical experience and follow-up care improve not only in the management of exstrophy, but for all complex anomalies as a result of the collaboration. This study confirms that ours is a model to emulate in reducing the surgical burden in this part of the world."

The goals of this program were to not only to address the complex surgical challenges associated with BE and deliver outcomes that would be expected in high-income countries, but also to transmit knowledge to provide long-term patient care for the future. The team accomplished this by partnering with Civil Hospital, which served as a location to train and perform surgeries. Surgeons local to India learned and participated in the procedures so that, with time, they are able to perform them on their own.

A contributor to this collaboration's success was rigorous patient follow-up, which resulted in improved patient outcomes and an accelerated surgical learning curve for participating surgeons. The results were impressive: 76 percent of patients who underwent complete primary repair of BE during the study interval returned for annual follow up in 2016. The same team that performed the surgeries was present for follow up, which helped to ensure cohesive care. Additionally, the team shared resources and infrastructure of academic research centers from higher-income countries.

"This was not simply mission work, it was an opportunity to provide long-term sustainability to our mission and deliver the highest levels of treatment," said Dr. Shukla. "I first traveled to India in 2002, and was awed by the volume and diversity of pathology. I was also moved by the massive burden of surgical disease in children. With Dr. Joshi, we resolved to help change the staggering statistics. While the work in India has been inspiring, we hope that this team and our study will inspire others to implement a similar collaboration model in other countries so they can continue transmitting knowledge and delivering care where it is needed most."

Philanthropy greatly helped power this work. Funding was made possible by generous donors and institutional funds.

In addition to Dr. Shukla's work at CHOP, he is also an Associate Professor of Urology in Surgery in the Perelman School of Medicine at the University of Pennsylvania.

"The International Bladder Exstrophy Consortium: A Model for Sustained Collaboration to Address the Unmet Global Burden of Surgical Disease," JAMA Surgery, March 7, 2018

About Children's Hospital of Philadelphia

Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. In addition, its unique family-centered care and public service programs have brought the 546-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu

Contact: Children's Hospital of Philadelphia
Kaila Conti
[email protected]
267-426-6054

SOURCE Children's Hospital of Philadelphia


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: